Product Program year 2021 Source: CMS Open Payments

Skyla

Drug Women's Health

NDC 50419-422-01

Open in the dashboard

General payments

$189,251

7,065 payments

Research payments

$140,719

5 payments

Through program year 2021, $189,251 in general payments and $140,719 in research payments were reported against Skyla (Women's Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2021 General $26,313 1,308
2021 Research $9,645 1
2020 General $49,687 1,640
2020 Research $63,551 2
2019 General $113,251 4,117
2019 Research $67,523 2

Breakdown

Who paid General payments · program years 2019–2021
  1. Bayer HealthCare Pharmaceuticals Inc. $189,251 7,065 payments
Top recipients General payments · program year 2021
  1. Samir Ahuja Obstetrics & Gynecology · Mentor, OH $714 3% · 3 payments
  2. Kimberly Lemoine Obstetrics & Gynecology · Saint Louis, MO $700 3% · 1 payment
  3. Leigh Johnson Family Medicine · Johnson City, TN $590 2% · 1 payment
  4. Aaron Hoffman Family Medicine · Boston, MA $590 2% · 1 payment
  5. Cheryl Lambing Family Medicine · Ventura, CA $590 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Obstetrics & Gynecology $15,438 59% · 529 practitioners
  2. Family Medicine $2,998 11% · 41 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $1,187 5% · 57 practitioners
  4. Advanced Practice Midwife $1,089 4% · 55 practitioners
  5. Nurse Practitioner, Women's Health Nurse Practitioner $1,087 4% · 48 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $7,183 27% · 161 recipients
  2. Georgia $2,676 10% · 102 recipients
  3. Indiana $2,483 9% · 123 recipients
  4. California $2,110 8% · 38 recipients
  5. Nevada $1,771 7% · 93 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

7,065 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record